Network Pharmacology and Traditional Chinese Medicine

Traditional Chinese medicine (TCM), an age-old healthcare system derived from China, is a mainstream medicine in China and is also popular in many other parts of the world [1-3]. Due to historic reasons, the scientific base of TCM awaits consolidation but emerging evidence has be‐ gun to illustrate TCM as an area of important medical rediscoveries. For example, the 2011 Lask‐ er-DeBakey Clinical Medical Research Award was awarded to Youyou Tu for the discovery of Chinese herb-derived artemisinin, a drug for malaria that has saved millions of lives across the globe [4,5] and the 7th Annual Szent-Gyorgyi Prize was awarded to Zhen-Yi Wang and Zhu Chen for their TCM research that led to the successful development of a new therapeutic approach to acute promyelocytic leukaemia. These award-winning projects were both conducted well be‐ fore the human genome was decoded and when information technology was in infancy. What has TCM to offer in the post-genomic era and the Information Age? To address this important question, the GP-TCM project kicked in as the 1st EU-funded EU-China collaboration dedicated to applying emerging technologies to TCM research [6,7]. Besides the consensus that omics and systems biology approaches will likely play major roles in addressing the complexity of TCM [7-9], more than half GP-TCM consortium members who responded to a consortium survey also cast votes of confidence in network pharmacology in TCM research [7]. Then, what is network pharmacology? What is the state of the art of this technology in modern pharmacological and toxicological studies, and finally, what are its possible roles in TCM research?

[1]  Ushma S. Neill.  From branch to bedside: Youyou Tu is awarded the 2011 Lasker~DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria. , 2011, The Journal of clinical investigation.

[2]  Wei Zhu,et al.  Computational network pharmacological research of Chinese medicinal plants for chronic kidney disease , 2010 .

[3]  Xiaohua Ma,et al.  Mechanisms of drug combinations: interaction and network perspectives , 2009, Nature Reviews Drug Discovery.

[4]  George Loizou,et al.  Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  Albert-László Barabási,et al.  Scale-Free Networks: A Decade and Beyond , 2009, Science.

[6]  Liang Liu,et al.  Network-based drug discovery by integrating systems biology and computational technologies , 2012, Briefings Bioinform..

[7]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[8]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[9]  Qihe Xu,et al.  Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future. , 2012, Journal of ethnopharmacology.

[10]  De-An Guo,et al.  Proteomics Characterization of the Cytotoxicity Mechanism of Ganoderic Acid D and Computer-automated Estimation of the Possible Drug Target Network*S , 2008, Molecular & Cellular Proteomics.

[11]  D. Guo,et al.  Establishing an EU-China consortium on traditional Chinese medicine research , 2010, Chinese medicine.

[12]  Thomas M. Ehrman,et al.  Phytochemical Databases of Chinese Herbal Constituents and Bioactive Plant Compounds with Known Target Specificities. , 2007 .

[13]  A. Hopkins.  Network pharmacology , 2007, Nature Biotechnology.

[14]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[15]  Barbara M. Bakker,et al.  Emergence of the silicon human and network targeting drugs. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  Bo Zhang,et al.  Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae , 2010, BMC Bioinform..

[17]  T. Gowers,et al.  Massively collaborative mathematics , 2009, Nature.

[18]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[19]  Yiyu Cheng,et al.  [Network pharmacology study on major active compounds of Fufang Danshen formula]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[20]  Hao Ye,et al.  HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..

[21]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[22]  Gary D Bader,et al.  How to visually interpret biological data using networks , 2009, Nature Biotechnology.

[23]  Jeffrey Bjoraker,et al.  A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906 , 2010, Chinese medicine.

[24]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[25]  Yung-chi Cheng,et al.  The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity , 2010, Science Translational Medicine.

[26]  Guan-hua Du,et al.  [Network pharmacology: new guidelines for drug discovery]. , 2010, Yao xue xue bao = Acta pharmaceutica Sinica.

[27]  Cheng Xiao,et al.  A network-based analysis of traditional Chinese medicine cold and hot patterns in rheumatoid arthritis. , 2012, Complementary therapies in medicine.

[28]  Yi Sun,et al.  Towards a bioinformatics analysis of anti-Alzheimer's herbal medicines from a target network perspective , 2013, Briefings Bioinform..

[29]  S. Ekins,et al.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling , 2007, British journal of pharmacology.

[30]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[31]  Edda Klipp,et al.  Systems Biology , 1994 .

[32]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[33]  Guowang Xu,et al.  Systems Biology Guided by Chinese Medicine Reveals New Markers for Sub-Typing Rheumatoid Arthritis Patients , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[34]  Albert,et al.  Emergence of scaling in random networks , 1999, Science.

[35]  Haifeng Sun,et al.  Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry. , 2011, Journal of ethnopharmacology.

[36]  Yiyu Cheng,et al.  [Symptom-based traditional Chinese medicine slices relationship network and its network pharmacology study]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[37]  B. Palsson,et al.  The evolution of molecular biology into systems biology , 2004, Nature Biotechnology.

[38]  L. Defrancesco.  Omics gets personal , 2012, Nature Biotechnology.

[39]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[40]  Fredrik Barrenäs,et al.  Network properties of human disease genes with pleiotropic effects , 2010, BMC Systems Biology.

[41]  Petter Holme,et al.  Network Properties of Complex Human Disease Genes Identified through Genome-Wide Association Studies , 2009, PloS one.

[42]  Thomas M. Ehrman,et al.  Phytochemical Databases of Chinese Herbal Constituents and Bioactive Plant Compounds with Known Target Specificities , 2007, J. Chem. Inf. Model..

[43]  M. Jamei,et al.  Physiologically-Based Pharmacokinetics , 2011 .

[44]  Cheng Xiao,et al.  Correlation between cold and hot pattern in traditional Chinese medicine and gene expression profiles in rheumatoid arthritis , 2011, Frontiers of medicine.

[45]  K. Shokat,et al.  Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases , 2008, Nature chemical biology.

[46]  Tianhan Xue,et al.  Studying Traditional Chinese Medicine , 2003, Science.

[47]  Z. Wen,et al.  Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map , 2011, PloS one.

[48]  D. K. Arrell,et al.  Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.

[49]  J. Greef,et al.  Rescuing drug discovery: in vivo systems pathology and systems pharmacology , 2005, Nature Reviews Drug Discovery.

[50]  Gergely Zahoránszky-Köhalmi,et al.  Drug Effect Prediction by Polypharmacology-Based Interaction Profiling , 2012, J. Chem. Inf. Model..

[51]  D. Normile.  The New Face of Traditional Chinese Medicine , 2003, Science.

[52]  E. Schadt.  Molecular networks as sensors and drivers of common human diseases , 2009, Nature.

[53]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[54]  Tai-Ping Fan,et al.  Omics and its potential impact on R&D and regulation of complex herbal products. , 2012, Journal of Ethnopharmacology.

[55]  G. Vaidyanathan.  Redefining Clinical Trials: The Age of Personalized Medicine , 2012, Cell.

[56]  Shao Li,et al.  [Network target: a starting point for traditional Chinese medicine network pharmacology]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[57]  I. Eberini,et al.  In-silico studies in Chinese herbal medicines’ research: Evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date , 2012, Journal of Ethnopharmacology.

[58]  M. Joyner,et al.  Physiology: alone at the bottom, alone at the top , 2011, The Journal of physiology.

[59]  Qian Liu,et al.  [Prediction of multi-target of Aconiti Lateralis Radix Praeparata and its network pharmacology]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[60]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.

[61]  K. Shokat,et al.  Targeting the cancer kinome through polypharmacology , 2010, Nature Reviews Cancer.

[62]  John P. Overington,et al.  Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.

[63]  M. Vidal,et al.  Edgetic perturbation models of human inherited disorders , 2009, Molecular systems biology.

[64]  X. Su,et al.  Artemisinin: Discovery from the Chinese Herbal Garden , 2011, Cell.

[65]  R. Bauer,et al.  Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities. , 2012, Journal of ethnopharmacology.

[66]  Yingdong Zhao,et al.  Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment , 2011, BMC Medical Genomics.

[67]  P. Unschuld.  What Is Medicine?: Western and Eastern Approaches to Healing , 2009 .

[68]  Shao Li,et al.  Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. , 2010, Molecular bioSystems.

[69]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[70]  D. Swinney,et al.  How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.

[71]  P Vicini,et al.  Multiscale Modeling in Drug Discovery and Development: Future Opportunities and Present Challenges , 2010, Clinical pharmacology and therapeutics.

[72]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[73]  Dennis Normile,et al.  Asian medicine. The new face of traditional Chinese medicine. , 2003, Science.

[74]  R. Iyengar,et al.  Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. , 2012, Annual review of pharmacology and toxicology.

[75]  Thomas Hartung,et al.  Food for Thought … Systems Toxicology , 2012 .